Correction: A roadmap to reduce the incidence and mortality of breast cancer by rethinking our approach to women's health.

IF 3 3区医学 Q2 ONCOLOGY Breast Cancer Research and Treatment Pub Date : 2024-12-20 DOI:10.1007/s10549-024-07572-8

Katherine Leggat-Barr, Douglas Yee, Erin Duralde, Caroline Hodge, Virginia Borges, Molly Baxter, Jessica Valdez, Tamandra Morgan, Judy Garber, Laura Esserman

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

更正：通过重新思考我们对妇女健康的态度，降低乳腺癌发病率和死亡率的路线图。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Breast Cancer Research and Treatment 医学-肿瘤学

CiteScore

6.80

自引率

2.60%

发文量

342

审稿时长

1 months

期刊介绍： Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.

期刊最新文献

Contribution of large genomic rearrangements in BRCA1/2 genes and CHEK2 1100delC allele variant to the development of breast/ovarian cancer in Argentinian population. Correction: A roadmap to reduce the incidence and mortality of breast cancer by rethinking our approach to women's health. Pooled clinical trial analyses evaluating outcomes of HER2-low vs HER2-0 expression in patients with metastatic breast cancer following chemotherapy. Diagnostic performance of MRI-guided vacuum-assisted breast biopsy (VABB): an essential but still underused technique. Education and mammographic breast density.